Evidence map›Paper›PMID 38879442›Full record

ArticleJournal of neuropathology and experimental neurology2024

Primary CNS histiocytic sarcoma: Two case reports highlighting a novel MIGA2::BRAF gene fusion and genome-wide DNA methylation profiling results.

Ryan Cecchi, Doré Guptil, Nicholas Haslett, Alexandra Hristov, Jacob R Bledsoe, Harrison Tsai, John DeWitt, Sean P Ferris

Abstract readCase ReportsLetter
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. A young man with multifocal brainstem leptomeningeal disease.Brain pathology (Zurich, Switzerland) · 2025
    Article
  3. Histiocytic Sarcoma: A Review and Update.International journal of molecular sciences · 2025
    Review
  4. NovelInternational journal of molecular sciences · 2025
    Review
  5. Article
  6. Article
  7. A 55-year-old man with a cerebral mass.Brain pathology (Zurich, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ryan CecchiDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI, United States.
Doré GuptilDepartment of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, VT, United States.
Nicholas HaslettDepartment of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, VT, United States.
Alexandra HristovDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI, United States.
Jacob R BledsoeDepartment of Pathology, Boston Children's Hospital, Boston, MA, United States.
Harrison TsaiDepartment of Pathology, Boston Children's Hospital, Boston, MA, United States.
John DeWittDepartment of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, VT, United States.
Sean P FerrisDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI, United States.ORCID 0000-0001-5407-7212

Funding

NCI NIH HHSNIHNIH HHS
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DNA MethylationHistiocytic SarcomaMembrane ProteinsMitochondrial ProteinsProto-Oncogene Proteins B-rafAdultCentral Nervous System NeoplasmsFemaleHumansMaleMiddle AgedTumor Suppressor ProteinsBRAF protein, humanMembrane ProteinsMitochondrial ProteinsProto-Oncogene Proteins B-rafTumor Suppressor Proteins

Identifiers

PMID38879442
PMCPMC11413427

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.